APA

De Placido S., De Laurentiis M., De Lena M., Lorusso V., Paradiso A., D'Aprile M., Pistillucci G., Farris A., Sarobba M. G., Palazzo S., Manzione L., Adamo V., Palmeri S., Ferraù F., Lauria R., Pagliarulo C., Petrella G., Limite G., Costanzo R. & Bianco A. R. (20050330). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. : British journal of cancer.

Chicago

De Placido S, De Laurentiis M, De Lena M, Lorusso V, Paradiso A, D'Aprile M, Pistillucci G, Farris A, Sarobba M G, Palazzo S, Manzione L, Adamo V, Palmeri S, Ferraù F, Lauria R, Pagliarulo C, Petrella G, Limite G, Costanzo R and Bianco A R. 20050330. A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. : British journal of cancer.

Harvard

De Placido S., De Laurentiis M., De Lena M., Lorusso V., Paradiso A., D'Aprile M., Pistillucci G., Farris A., Sarobba M. G., Palazzo S., Manzione L., Adamo V., Palmeri S., Ferraù F., Lauria R., Pagliarulo C., Petrella G., Limite G., Costanzo R. and Bianco A. R. (20050330). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. : British journal of cancer.

MLA

De Placido S, De Laurentiis M, De Lena M, Lorusso V, Paradiso A, D'Aprile M, Pistillucci G, Farris A, Sarobba M G, Palazzo S, Manzione L, Adamo V, Palmeri S, Ferraù F, Lauria R, Pagliarulo C, Petrella G, Limite G, Costanzo R and Bianco A R. A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. : British journal of cancer. 20050330.